UNITED THERAPEUTICS Corp Quarterly Nonoperating Income (Expense) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
UNITED THERAPEUTICS Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2010 to Q3 2024.
  • UNITED THERAPEUTICS Corp Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $45.5M, a 83.5% increase year-over-year.
  • UNITED THERAPEUTICS Corp Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $159M, a 177% increase year-over-year.
  • UNITED THERAPEUTICS Corp annual Nonoperating Income (Expense) for 2023 was $89.4M.
  • UNITED THERAPEUTICS Corp annual Nonoperating Income (Expense) for 2022 was -$29.1M, a 177% decline from 2021.
  • UNITED THERAPEUTICS Corp annual Nonoperating Income (Expense) for 2021 was $38M, a 16.1% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $159M $45.5M +$20.7M +83.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $138M $35.4M +$13.6M +62.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $124M $42.3M +$34.8M +464% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $89.4M $35.3M +$32.1M +1003% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 $57.3M $24.8M +$26.6M Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $30.7M $21.8M +$73M Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 -$42.3M $7.5M -$13.2M -63.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 -$29.1M $3.2M +$32.5M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 -$61.6M -$1.8M +$22.5M +92.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 -$84.1M -$51.2M -$45.5M -798% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 -$38.6M $20.7M -$76.6M -78.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $38M -$29.3M -$78.4M -160% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 $116M -$24.3M -$22.2M -1057% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $139M -$5.7M +$900K +13.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $138M $97.3M +$92.4M +1886% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $45.3M $49.1M +$44.3M +923% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-22
Q3 2020 $1M -$2.1M +$14.4M +87.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$13.4M -$6.6M -$35.6M -123% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $22.2M $4.9M -$400K -7.55% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $22.6M $4.8M +$44.4M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 -$21.8M -$16.5M -$7M -73.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-28
Q2 2019 -$14.8M $29M +$28.5M +5700% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 -$43.3M $5.3M +$3.2M +152% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 -$46.5M -$39.6M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 -$9.5M -$6.4M -206% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $500K +$44.8M Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $2.1M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q3 2017 -$3.1M -$3.6M -720% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 -$44.3M -$44.8M -8960% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q4 2016 -$1.5M -$2.7M -$3.7M -370% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $2.2M $500K -$349M -99.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-25
Q2 2016 $352M $500K +$3.9M Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-27
Q1 2016 $348M $200K +$2.2M Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-26
Q4 2015 $345M $1M +$4.79M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-21
Q3 2015 $341M $350M +$353M Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-27
Q2 2015 -$12.8M -$3.4M -$113K -3.44% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-28
Q1 2015 -$12.7M -$2M +$924K +31.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-28
Q4 2014 -$13.6M -$3.79M -$653K -20.8% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-22
Q3 2014 -$12.9M -$3.6M -$127K -3.66% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-27
Q2 2014 -$12.8M -$3.29M +$498K +13.2% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-28
Q1 2014 -$13.3M -$2.92M +$278K +8.68% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-28
Q4 2013 -$13.6M -$3.14M +$512K +14% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-25
Q3 2013 -$14.1M -$3.47M -$31.2M -112% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 $17.1M -$3.79M -$1.49M -64.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-29
Q1 2013 $18.6M -$3.2M -$401K -14.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-29
Q4 2012 $19M -$3.65M +$674K +15.6% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-24
Q3 2012 $18.4M $27.8M +$32.5M Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-29
Q2 2012 -$14.1M -$2.3M +$2.58M +52.9% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-25
Q1 2012 -$16.7M -$2.8M +$1.94M +40.9% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-25
Q4 2011 -$18.7M -$4.33M +$217K +4.78% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 -$18.9M -$4.72M -$574K -13.8% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 -$18.3M -$4.88M -$971K -24.8% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-26
Q1 2011 -$17.3M -$4.74M -$1.18M -33% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-26
Q4 2010 -$16.2M -$4.54M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-26
Q3 2010 -$4.15M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-27
Q2 2010 -$3.91M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-28
Q1 2010 -$3.57M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.